Almeda Ventures Limited Partnership
Almeda Ventures Limited Partnership is a venture capital firm specializing in seed, start up, early venture and middle market investments. The firm seeks to invest in health technology with focus on public R&D partnership, medical devices, digital health and bio-convergence; life sciences research and development company. It prefers to invest in Israel, USA and Europe. Almeda Ventures Limited Par… Read more
Almeda Ventures Limited Partnership (AMDA) - Net Assets
Latest net assets as of June 2025: ILA21.76 Million ILA
Based on the latest financial reports, Almeda Ventures Limited Partnership (AMDA) has net assets worth ILA21.76 Million ILA as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA21.93 Million) and total liabilities (ILA170.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA21.76 Million |
| % of Total Assets | 99.22% |
| Annual Growth Rate | 4.51% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 21.99 |
Almeda Ventures Limited Partnership - Net Assets Trend (2020–2024)
This chart illustrates how Almeda Ventures Limited Partnership's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Almeda Ventures Limited Partnership (2020–2024)
The table below shows the annual net assets of Almeda Ventures Limited Partnership from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA22.64 Million | -10.53% |
| 2023-12-31 | ILA25.31 Million | -5.87% |
| 2022-12-31 | ILA26.88 Million | -1.78% |
| 2021-12-31 | ILA27.37 Million | +44.23% |
| 2020-12-31 | ILA18.98 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Almeda Ventures Limited Partnership's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 637300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA29.00 Million | 128.06% |
| Other Comprehensive Income | ILA294.00K | 1.30% |
| Other Components | ILA1.00 | 0.00% |
| Total Equity | ILA22.64 Million | 100.00% |
Almeda Ventures Limited Partnership Competitors by Market Cap
The table below lists competitors of Almeda Ventures Limited Partnership ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Owl Rock Capital Corporation
F:1D6
|
$90.85K |
|
NOKIAN TYRES - Dusseldorf Stock Exchang
DU:NRE
|
$90.88K |
|
IRBR3F
SA:IRBR3F
|
$90.99K |
|
Peab AB
STU:PEKB
|
$91.08K |
|
CHIBA BANK
BE:CBR
|
$90.79K |
|
Fundo De Investimento Imobiliario Ourinvest Re I
SA:WTSP11
|
$90.79K |
|
ENERGY RECOVERY (5E2.SG)
STU:5E2
|
$90.77K |
|
REMGRO
MU:RE7
|
$90.77K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Almeda Ventures Limited Partnership's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 25,307,000 to 22,641,000, a change of -2,666,000 (-10.5%).
- Net loss of 4,202,000 reduced equity.
- Other comprehensive income increased equity by 230,000.
- Other factors increased equity by 1,306,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-4.20 Million | -18.56% |
| Other Comprehensive Income | ILA230.00K | +1.02% |
| Other Changes | ILA1.31 Million | +5.77% |
| Total Change | ILA- | -10.53% |
Book Value vs Market Value Analysis
This analysis compares Almeda Ventures Limited Partnership's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 123.09x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 32.30x to 123.09x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | ILA6.80 | ILA219.80 | x |
| 2021-12-31 | ILA1.46 | ILA219.80 | x |
| 2022-12-31 | ILA2.17 | ILA219.80 | x |
| 2023-12-31 | ILA2.05 | ILA219.80 | x |
| 2024-12-31 | ILA1.79 | ILA219.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Almeda Ventures Limited Partnership utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: -0.13x
- • Equity Multiplier: 1.02x
- Recent ROE (-18.56%) is below the historical average (-5.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -2.48% | 0.00% | 0.00x | 1.01x | ILA-2.37 Million |
| 2021 | 0.19% | 3.26% | 0.06x | 1.02x | ILA-2.69 Million |
| 2022 | -2.38% | -70.67% | 0.03x | 1.01x | ILA-3.33 Million |
| 2023 | -6.25% | 0.00% | -0.01x | 1.02x | ILA-4.11 Million |
| 2024 | -18.56% | 0.00% | -0.13x | 1.02x | ILA-6.47 Million |
Industry Comparison
This section compares Almeda Ventures Limited Partnership's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $9,880,000
- Average return on equity (ROE) among peers: -10.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Almeda Ventures Limited Partnership (AMDA) | ILA21.76 Million | -2.48% | 0.01x | $90.83K |
| Imed Infinity Medical-Limited Partnership (IMED) | $9.88 Million | -10.18% | 0.01x | $12.22K |